3[1]Kawamura T,Tamakoshi A,Wakai K,et al.Evidence-based medicine and the cochrane collaboration[J].Nippon Koshu Eisei Zasshi,1999,46(6):498-506.
4Heidenreich PA,Alloggiamento T.The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes:a meta-analysis.J Am Coll Cardiol,2001,38:478-485.
5Cagliero E,Levina EV.Immediate feedback of HbA1C levels improves glycamic control in type 1 and insulin-treated type 2 diabetic patients.Diabetes Care,1999,22:1785-1789.
6Parvin CA,Lo SF.Impact of point of care testing on patient′s length of stay in a large emergency department.Clin Chem,1996,42:711-717.
7Anderson FP,Fritz ML.Cost-effectiveness of cardiac troponin I in a systematic chest pain evaluation protocol:use of cardiac troponin I lowers lenth of stay for low-risk cardiac patients.Clin Lab Manage Rev,1998,12:63-69.
8Drummond MF,O'Brien B.Methods for the economic evaluation of health care programs,2nd ed.Toronto,Oxford University press,1997.
9Westgard JO,Barry PO.Cost-effectiveness quality control:managing the quality and productivity of analytical process.4th ed.Washington DC,AACC Press,1995.
10Carle E S.The right test:a physician′s guide to laboratory medicine.3nd ed.Philadelphia,Suanders company,1998.
